Jieying Liu, M.D.

DSCF0966-e1760131590340
Clinical Research Principle Investigator
Find a Clinical Trial

Languages Spoken

English, Mandarin

Locations

Biography

Dr. Jieying Liu is a board-certified internal medicine physician and oncologist with extensive experience in the treatment of malignant tumors.

She earned her medical degree from Peking Union Medical College in Beijing, China, where she also completed her residency and fellowship training in medical oncology at Peking Union Medical College Hospital. She continued her training in the United States, completing her Internal Medicine residency at AdventHealth Orlando and her Medical Oncology fellowship at East Tennessee State University, where she served as Chief Fellow.

Dr. Liu joined The Oncology Institute of Hope and Innovation in September 2025 as an attending physician. She has broad experience in managing a wide range of malignancies, with particular expertise in gastrointestinal and breast cancers. Her research interests include immunotherapy, stem cell transplantation, and oncology outcomes during the COVID-19 pandemic. She has authored multiple peer-reviewed publications and presented her work at national medical conferences.

Education

Fellowship
AdventHealth Orlando, Orlando, FL
• Internal Medicine (2020–2023)

Residency
East Tennessee State University, Johnson City, TN
• Medical Oncology (Chief Fellow, 2023–2025)

Medical Education
Peking Union Medical College, Beijing, China
• Doctor of Medicine (2001–2009)

Professional Memberships

  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)